Skip to main content
Jeffrey Leiden, MD, Cardiology, Abbott Park, IL

JeffreyMLeidenMD

Cardiology • Abbott Park, IL

Adult Congenital Heart Disease

Physician

Join to view full profile

Are you Dr. Leiden?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 56 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Jeffrey Leiden, MD is a cardiologist in Abbott Park, Illinois. He is currently licensed to practice medicine in Illinois and Massachusetts.

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1984 - 1985
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1981 - 1984
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1981

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1983 - 2025
  • IL State Medical License
    IL State Medical License 1992 - 2017

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2001
  • Investigator Alumnus Howard Hughes Medical Institute, 1987

Publications & Presentations

PubMed

Press Mentions

  • Will the Workplace Ever Look the Same? MassMutal, UMass Amherst and TJX Share Their COVID Protocols for Employees Going Forward
    Will the Workplace Ever Look the Same? MassMutal, UMass Amherst and TJX Share Their COVID Protocols for Employees Going ForwardAugust 14th, 2021
  • FDA Warns Acceleron of Possible Fines for Not Posting Results from Failed Trial
    FDA Warns Acceleron of Possible Fines for Not Posting Results from Failed TrialApril 28th, 2021
  • Vertex Pharmaceuticals and CRISPR Therapeutics Amend Collaboration for Development, Manufacturing and Commercialization of CTX001™ in Sickle Cell Disease and Beta Thalassemia
    Vertex Pharmaceuticals and CRISPR Therapeutics Amend Collaboration for Development, Manufacturing and Commercialization of CTX001™ in Sickle Cell Disease and Beta ThalassemiaApril 20th, 2021
  • Join now to see all

Dr. Jeffrey Leiden, Dr. Jeffrey Leiden, MD, Dr. J Leiden, Dr. Jeffrey M Leiden